RNA interference screening identifies a novel role for PCTK1/CDK16 in medulloblastoma with c-Myc amplification

Medulloblastoma (MB) is the most common malignant brain tumor in children and is associated with a poor outcome. cMYC amplification characterizes a subgroup of MB with very poor prognosis. However, there exist so far no targeted therapies for the subgroup of MB with cMYC amplification. Here we used...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Ćwiek, Paulina, Leni, Zaira, Salm, Fabiana, Dimitrova, Valeriya, Styp-Rekowska, Beata, Chiriano, Gianpaolo, Carroll, Michael, Höland, Katrin, Djonov, Valentin, Scapozza, Leonardo, Guiry, Patrick, Arcaro, Alexandre
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2014
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4381582/
https://ncbi.nlm.nih.gov/pubmed/25402633
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados